Timpani Capital Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
FAM
WRF
GS
CS
NCGI
O
Timpani Capital Management's CDNA Position: Q1 2019 in Review
Timpani Capital Management increased its CareDx (CDNA) stake by 11% in Q1 2019, buying an estimated $392K and bringing the position to 136,167 shares worth $4.29M. The position accounts for 2.05% of the portfolio, ranked #12.
Timpani Capital Management first reported a position in CDNA in Q2 2018 and has held it in 4 quarters since. 182 funds tracked by Wall St. Rank hold CDNA as of Q1 2019.
- Timpani Capital Management held 136,167 shares of CareDx worth $4.29M as of Q1 2019.
- Timpani Capital Management bought 13,470 CareDx shares in Q1 2019, an estimated $392K.
- CareDx made up 2.05% of Timpani Capital Management's portfolio in Q1 2019, its #12 holding.
- Timpani Capital Management first reported a position in CareDx in Q2 2018 and has held it in 4 quarters since.
- 182 funds tracked by Wall St. Rank held CareDx as of Q1 2019.
Based on Timpani Capital Management's 13F filing for Q1 2019, filed 10 May 2019.